P592 A phase 1, double-blind placebo-controlled single-dose study to determine the immune response to systemic and mucosal antigenic challenge in the presence of vedolizumab

2013 ◽  
Vol 7 ◽  
pp. S248 ◽  
Author(s):  
T. Wyant ◽  
T. Leach ◽  
S. Sankoh ◽  
Y. Wang ◽  
J. Paolino ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document